Ashley Cimino‐Mathews

Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

Tricia R. Cottrell, Elizabeth D. Thompson, Patrick M. Forde et al. · Annals of Oncology · 2018 · 557 citations · Full text

Detection of Cancer DNA in Plasma of Patients with Early-Stage Breast Cancer

Julia A. Beaver, Danijela Jelovac, Balukrishna Sasidharan et al. · Clinical Cancer Research · 2014 · 392 citations · Full text

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas

Ashley Cimino‐Mathews, Elizabeth D. Thompson, Janis M. Taube et al. · Human Pathology · 2015 · 334 citations · Full text

Breast Oncology, Cancer Immunosurveillance, Immunology +8

Safety and Clinical Activity of the Programmed Death-Ligand 1 Inhibitor Durvalumab in Combination With Poly (ADP-Ribose) Polymerase Inhibitor Olaparib or Vascular Endothelial Growth Factor Receptor 1-3 Inhibitor Cediranib in Women's Cancers: A Dose-Escalation, Phase I Study

Jung Min Lee, Ashley Cimino‐Mathews, Cody J. Peer et al. · Journal of Clinical Oncology · 2017 · 235 citations · Full text

Immunology, Olaparib Tablets, Pharmacotherapy +20

GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas

Ashley Cimino‐Mathews, Andrea P. Subhawong, Peter B. Illei et al. · Human Pathology · 2013 · 223 citations · Full text

Breast Oncology, Oncology, Medicine +9